00:00
00:00
00:00
ValiRx - Quarterly update on clinical developments

Dr George Morris, Chief Operating Officer, discusses the update announced by Valirx, with VAL201 continuing to perform well as expected, TRAC technology being sold to to Sovicell Science for Life GmbH, and VAL401 continuing its trial.

Dr George Morris
Chief Operating Officer

Company Events - VALIRX PLC